Prospective epidemiological studies have consistently demonstrated that cannabis use is
associated with an increased subsequent risk of both psychotic symptoms and …

The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision.
Therefore, the search of biomarkers is a fundamental aspect in psychiatry to reach a more …

Objectives The liberalisation of cannabis laws, the increasing availability and potency of
cannabis has renewed concern about the risk of psychosis with cannabis. Methods The …

The possible role of the CB 2 receptor (CB 2 r) in psychiatric disorders has been considered.
Several animal models use knockout (KO) mice that display schizophrenia-like behaviors …

Despite widespread evidence of endocannabinoid system involvement in the
pathophysiology of psychiatric disorders, our understanding remains rudimentary. Here we …

Several studies have examined the link between the cannabinoid CB1 receptor and several
neuropsychiatric illnesses, including schizophrenia. As such, there is a need for in vivo …

Adenosine and adenosine receptors (ARs) are increasingly recognized as important
therapeutic targets for controlling cognition under normal and disease conditions for its dual …

Although cannabis use is associated with an increased risk of developing psychosis, the
cannabis constituent cannabidiol (CBD) may have antipsychotic properties. This review …

Abstract Dopamine 2 receptor (DRD2) is of major interest to the pathophysiology of
schizophrenia (SCZ) both as a target for antipsychotic drug action as well as a SCZ …

Serine/threonine protein kinase v-akt murine thymoma viral oncogene homolog (Akt) is one
of the survival kinases with multiple biological functions in the brain and throughout the …